StonvexLoading…
StonvexStonvexStonvexCore line items from BKV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $893.78M | $604.53M | $739.28M | $1.66B |
Operating Income | $217.61M | $-154.80M | $157.62M | $304.56M |
Net Income | $173.13M | $-142.87M | $116.92M | $410.14M |
EPS (Diluted) | $1.98 | $-2.00 | $1.82 | $6.62 |
Total Assets | $3.13B | $2.23B | $2.68B | Not available |
Total Liabilities | $1.07B | $671.51M | $1.21B | Not available |
Cash & Equivalents | $199.41M | $14.87M | $25.41M | $153.13M |
Free Cash Flow OCF − CapEx | $-57.46M | $17.62M | $-64.64M | Not available |
Shares Outstanding | 96.87M | 84.60M | 63.87M | 61.99M |